Cite
HARVARD Citation
Li, J. et al. (2015). Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer. Medicine. 94 (41), pp. e1340-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, J. et al. (2015). Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer. Medicine. 94 (41), pp. e1340-. [Online].